<li>amitriptyline<p>amitriptyline, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>amoxapine<p>amoxapine, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>cabergoline<p>cabergoline, dextroamphetamine. Mechanism: pharmacodynamic synergism. Contraindicated. Additive vasospasm; risk of hypertension.</p></li><li>clomipramine<p>clomipramine, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>desflurane<p>desflurane increases toxicity of dextroamphetamine by Mechanism: unknown. Avoid or Use Alternate Drug. Risk of V tach, HTN.</p></li><li>desipramine<p>desipramine, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>desvenlafaxine<p>dextroamphetamine and desvenlafaxine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>dihydroergotamine<p>dihydroergotamine, dextroamphetamine. Mechanism: pharmacodynamic synergism. Contraindicated. Additive vasospasm; risk of hypertension.</p></li><li>dihydroergotamine intranasal<p>dihydroergotamine intranasal, dextroamphetamine. Mechanism: pharmacodynamic synergism. Contraindicated. Additive vasospasm; risk of hypertension.</p></li><li>dosulepin<p>dosulepin, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>doxapram<p>doxapram increases effects of dextroamphetamine by pharmacodynamic synergism. Avoid or Use Alternate Drug. Additive pressor effect.</p></li><li>doxepin<p>doxepin, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>enflurane<p>enflurane increases toxicity of dextroamphetamine by Mechanism: unknown. Avoid or Use Alternate Drug. Risk of V tach, HTN.</p></li><li>ergoloid mesylates<p>ergoloid mesylates, dextroamphetamine. Mechanism: pharmacodynamic synergism. Contraindicated. Additive vasospasm; risk of hypertension.</p></li><li>ergonovine<p>ergonovine, dextroamphetamine. Mechanism: pharmacodynamic synergism. Contraindicated. Additive vasospasm; risk of hypertension.</p></li><li>ergotamine<p>ergotamine, dextroamphetamine. Mechanism: pharmacodynamic synergism. Contraindicated. Additive vasospasm; risk of hypertension.</p></li><li>ether<p>ether increases toxicity of dextroamphetamine by Mechanism: unknown. Avoid or Use Alternate Drug. Risk of V tach, HTN.</p></li><li>imipramine<p>imipramine, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>isocarboxazid<p>isocarboxazid increases levels of amphetamine by decreasing metabolism. Avoid or Use Alternate Drug. Slowing amphetamine metabolism potentiates amphetamines, increasing their affect on the release of norepinephrine and other monoamines from adrenergic nerve endings. This can cause headaches and other signs of hypertensive crisis. A variety of neurological toxic effects and malignant hyperpyrexia can occur, sometimes with fatal results.<span><br><br></span>isocarboxazid and dextroamphetamine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>isoflurane<p>isoflurane increases toxicity of dextroamphetamine by Mechanism: unknown. Avoid or Use Alternate Drug. Risk of V tach, HTN.</p></li><li>phenelzine<p>phenelzine increases levels of amphetamine by decreasing metabolism. Avoid or Use Alternate Drug. Slowing amphetamine metabolism potentiates amphetamines, increasing their affect on the release of norepinephrine and other monoamines from adrenergic nerve endings. This can cause headaches and other signs of hypertensive crisis. A variety of neurological toxic effects and malignant hyperpyrexia can occur, sometimes with fatal results.</p></li><li>linezolid<p>linezolid and dextroamphetamine both increase  serotonin levels. Avoid or Use Alternate Drug. Linezolid may increase serotonin as a result of MAO-A inhibition. If linezolid must be administered, discontinue serotonergic drug immediately and monitor for CNS toxicity. Serotonergic therapy may be resumed 24 hours after last linezolid dose or after 2 weeks of monitoring, whichever comes first.</p></li><li>lofepramine<p>lofepramine, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>lorcaserin<p>dextroamphetamine and lorcaserin both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>maprotiline<p>maprotiline, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>methoxyflurane<p>methoxyflurane increases toxicity of dextroamphetamine by Mechanism: unknown. Avoid or Use Alternate Drug. Risk of V tach, HTN.</p></li><li>methylene blue<p>methylene blue and dextroamphetamine both increase  serotonin levels. Avoid or Use Alternate Drug. Methylene blue may increase serotonin as a result of MAO-A inhibition. If methylene blue must be administered, discontinue serotonergic drug immediately and monitor for CNS toxicity. Serotonergic therapy may be resumed 24 hours after last methylene blue dose or after 2 weeks of monitoring, whichever comes first.</p></li><li>methylergonovine<p>methylergonovine, dextroamphetamine. Mechanism: pharmacodynamic synergism. Contraindicated. Additive vasospasm; risk of hypertension.</p></li><li>mianserin<p>mianserin, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>nortriptyline<p>nortriptyline, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>phenelzine<p>phenelzine and dextroamphetamine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>procarbazine<p>procarbazine and dextroamphetamine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>protriptyline<p>protriptyline, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>sevoflurane<p>sevoflurane increases toxicity of dextroamphetamine by Mechanism: unknown. Avoid or Use Alternate Drug.</p></li><li>tedizolid<p>tedizolid, dextroamphetamine.
Either increases effects of the other by Mechanism: pharmacodynamic synergism. Avoid or Use Alternate Drug. both increase serotonin levels; increased risk of serotonin syndrome.</p></li><li>tranylcypromine<p>tranylcypromine increases levels of amphetamine by decreasing metabolism. Avoid or Use Alternate Drug. Slowing amphetamine metabolism potentiates amphetamines, increasing their affect on the release of norepinephrine and other monoamines from adrenergic nerve endings. This can cause headaches and other signs of hypertensive crisis. A variety of neurological toxic effects and malignant hyperpyrexia can occur, sometimes with fatal results.<span><br><br></span>tranylcypromine and dextroamphetamine both increase  serotonin levels. Avoid or Use Alternate Drug.</p></li><li>trazodone<p>trazodone, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>trimipramine<p>trimipramine, dextroamphetamine. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron.</p></li><li>vilazodone<p>dextroamphetamine, vilazodone.
Either increases toxicity of the other by serotonin levels. Avoid or Use Alternate Drug. Concomitant therapy should be discontinued immediately if signs or symptoms of serotonin syndrome emerge and supportive symptomatic treatment should be initiated.  .</p></li><li>yohimbe<p>yohimbe, dextroamphetamine. Mechanism: pharmacodynamic synergism. Contraindicated. Risk of acute hypertensive episode.</p></li>